tiprankstipranks
Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Financial Statements

Compare
762 Followers

Protalix Financial Overview

Protalix's market cap is currently $178.93M. The company's EPS TTM is $-0.142; its P/E ratio is ―; Protalix is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 65.49M$ 47.64M$ 38.35M$ 62.90M$ 54.69M
Gross Profit$ 42.51M$ 28.05M$ 22.00M$ 52.02M$ 43.80M
Operating Income$ 10.46M$ -13.01M$ -20.46M$ 1.85M$ -10.72M
EBITDA$ 11.65M$ -10.78M$ -18.94M$ 4.45M$ -8.69M
Net Income$ 8.31M$ -14.93M$ -33.98M$ -14.89M$ -26.24M
Balance Sheet
Cash & Short-Term Investments$ 44.56M$ 22.18M$ 38.98M$ 38.55M$ 17.79M
Total Assets$ 84.43M$ 55.79M$ 73.67M$ 67.93M$ 45.39M
Total Debt$ 26.28M$ 33.47M$ 33.47M$ 64.40M$ 60.92M
Net Debt$ 2.65M$ 16.36M$ -5.51M$ 46.13M$ 43.13M
Total Liabilities$ 50.87M$ 66.43M$ 79.70M$ 94.97M$ 115.71M
Stockholders' Equity$ 33.57M$ -10.64M$ -6.04M$ -27.04M$ -70.32M
Cash Flow
Free Cash Flow$ -2.47M$ -25.63M$ -11.74M$ -26.76M$ -19.98M
Operating Cash Flow$ -1.32M$ -25.00M$ -10.29M$ -26.11M$ -19.36M
Investing Cash Flow$ -16.71M$ -5.04M$ 18.92M$ -19.95M$ -883.00K
Financing Cash Flow$ 24.67M$ 8.24M$ 12.08M$ 46.47M$ 0.00
Currency in USD

Protalix Earnings and Revenue History

Protalix Debt to Assets

Protalix Cash Flow

Protalix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis